EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Re-programmed eosinophils drive allergic rhinitis via epigenetic and metabolic innate immune memory

Yun Liao, Yongmin Xie, Haiyang Han, Haoyue Zheng, Pingchang Yang iD, Gui Yang

Journal of Innate Immunity · 10.11.2026

DOI: 10.1159/jin/adhag005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 10.11.2026. Verfasst von Yun Liao und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic rhinitis (AR) is a prevalent recurrent upper airway inflammatory disorder. The lack of clarity on chronicity driving mechanisms hinders the development of precise treatments for severe, persistent allergic rhinitis.

Objective

This study aimed to uncover the epigenetic and metabolic basis of sustained AR inflammation and identify key cellular drivers and therapeutic targets for refractory AR.

Methods

We combined a two hit house dust mite (HDM) induced chronic AR mouse model and clinical samples from severe chronic AR patients. Integrated epigenetic profiling, metabolic assays, eosinophil depletion, IL 33–ST2 blockade, and clinical correlation analyses were performed to characterize pathogenic eosinophil programming.

Results

A long lived, epigenetically and metabolically programmed eosinophil subset drove chronic AR. Post acute inflammation resolution, eosinophil precursors exhibited elevated chromatin accessibility at Alox5, Il4ra, Pparg, and Csf2rb, forming persistent epigenetic imprinting. These eosinophils underwent PPARγ dependent fatty acid oxidation (FAO) reprogramming, with prolonged survival, reduced apoptosis, and heightened sensitivity to IL 33/C5a, promoting robust IL 4/IL 13 and LTC4 release. Targeted eosinophil depletion or IL 33–ST2 blockade relieved nasal inflammation and allergic symptoms. Consistently, severe AR patient eosinophils displayed enhanced FAO and ALOX5 accessibility, which positively correlated with LTC4 production.

Conclusion

Eosinophil innate immune memory via epigenetic and metabolic reprogramming sustains chronic AR. This conserved pathogenic signature provides a candidate biomarker for patient stratification and novel therapeutic targets for refractory upper airway allergy.

Autor:innen und Institutionen

ORCID-Profile: Pingchang Yang

Zitieren

APA

Liao, Y., Xie, Y., Han, H., Zheng, H., Yang, P., & Yang, G. (2026). Re-programmed eosinophils drive allergic rhinitis via epigenetic and metabolic innate immune memory. Journal of Innate Immunity. https://doi.org/10.1159/jin/adhag005

Vancouver

Liao Y, Xie Y, Han H, Zheng H, Yang P, Yang G. Re-programmed eosinophils drive allergic rhinitis via epigenetic and metabolic innate immune memory. Journal of Innate Immunity. 2026. doi:10.1159/jin/adhag005

BibTeX
@article{Liao2026,
  author = {Liao, Yun and Xie, Yongmin and Han, Haiyang and Zheng, Haoyue and Yang, Pingchang and Yang, Gui},
  title = {Re-programmed eosinophils drive allergic rhinitis via epigenetic and metabolic innate immune memory},
  journal = {Journal of Innate Immunity},
  year = {2026},
  doi = {10.1159/jin/adhag005}
}
Kostenlos starten →